Revenues (Tables)

6 Months Ended

Jun. 30, 2018

Revenues

Schedule of topic 606 on the Company's consolidated financial statements

	Balance at December 31, 2017			New Revenue Standard Adjustment			Balance at January 1, 2018
Assets
Prepaid and other current assets	$	2,865		$	555		$	3,420
Other assets		1,116			(199	)		917
Shareholders’ Equity
Accumulated Deficit		(69,597	)		356			(69,241	)

	Impact of changes in accounting policies Six months ended June 30, 2018
	As reported		Adj.			Balances without adoption of Topic 606
Service revenue	$	13,637	$	293		$	13,930
Product revenue		26,986		(162	)		26,824
Total revenues		40,623		131			40,754
Cost of revenues		19,336		-			19,336
Research and development expenses		2,359		-			2,359
Selling and marketing expenses		7,545		21			7,566
General and administrative expenses		5,548		-			5,548
Amortization of intangible assets		248		-			248
One time acquisition related costs		262		-			262
Financial expenses		666		-			666
Income tax expense		950		15			965
Others		15		-			15
Net income		3,694		95			3,789

Schedule of disaggregation of revenue

	Reportable segments results of operations for the six months ended June 30, 2018
	Cellocator segment		MRM segment		Elimination			Total
Revenue recognized:
At a point of time	$	12,367	$	5,634	$	(4,364	)	$	13,637
Over a period of time		362		26,670		(46	)		26,986
		12,729		32,304		(4,410	)		40,623

	Reportable segments about geographical areas
	For the six months ended June 30, 2018		For the year ended December 31, 2017
Revenues
Israel	$	19,293	$	35,230
Latin America (mainly Mexico)		5,936		9,603
Brazil		6,876		14,248
Argentina		2,067		4,607
Europe		2,265		4,413
Other		4,186		10,054
		40,623		78,155

Schedule of receivables, contracts assets, and contract liabilities from contracts with customers

	Balance at June 30, 2018		Balance at December 31, 2018
Contract assets	$	486	$	398